Long term survival of Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis: letter to the Editor
Journal | Volume 85 - 2022 |
Issue | Fasc.3 - Letters |
Author(s) | S.-P. Yeh 1, H.-L. Lin 2, C.-R. Chien 3 4 |
Full article |
PAGES 535-536 VIEW FREE PDF |
DOI | 10.51821/85.3.10559 |
Affiliations: (1) Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
(2) Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan (3) Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan (4) School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan |
We read the article by Chuan YY et al (1) with interest when we searched the literature to guide our care for a patient with Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis. Chuan YY et al (1) reported a patient with EATL developed intracranial involvement and died nine months after the initial diagnosis. They also summarized previous studies and found the survival after initial diagnosis was no longer than sixteen months. |
© Acta Gastro-Enterologica Belgica. PMID 36198299 |